venBio Partners LLC Long-Term Concentrated

CIK: 0001776382 · Show all filings

Period: Q2 2024 (← Previous) (Next →)

Filing Date: Aug 14, 2024

Total Value ($000): $231,516 (100.0% shares, 0.0% debt)

Holdings (6)

PHVS PHARVARIS N V 34.8%

Value ($000) $80,639 Shares 4,289,304 Est. Cost $21.15 Unrealized -3.8%

ALXO ALX ONCOLOGY HLDGS INC 25.3%

Value ($000) $58,491 Shares 9,699,925 Est. Cost $39.31 Unrealized -68.7%

ALMS ALUMIS INC 16.2%

Value ($000) $37,586 Shares 2,826,048 Est. Cost $13.30 Unrealized 0.0%

HRMY HARMONY BIOSCIENCES HLDGS IN 13.5%

Value ($000) $31,238 Shares 1,035,396 Est. Cost $36.46 Unrealized -17.5%

— ACELYRIN INC 7.3%

Value ($000) $16,989 Shares 3,852,470 Est. Cost $20.90 Unrealized —

— ELEVATION ONCOLOGY INC 2.8%

Value ($000) $6,572 Shares 2,434,255 Est. Cost $9.24 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
PHVS	PHARVARIS N V	4,289,304	$80,639	34.8%	$21.15	-3.8%	COM	N69605108
ALXO	ALX ONCOLOGY HLDGS INC	9,699,925	$58,491	25.3%	$39.31	-68.7%	COM	00166B105
ALMS	ALUMIS INC	2,826,048	$37,586	16.2%	$13.30	0.0%	COM	022307102
HRMY	HARMONY BIOSCIENCES HLDGS IN	1,035,396	$31,238	13.5%	$36.46	-17.5%	COM	413197104
—	ACELYRIN INC	3,852,470	$16,989	7.3%	$20.90	—	COM	00445A100
—	ELEVATION ONCOLOGY INC	2,434,255	$6,572	2.8%	$9.24	—	COM	28623U101